ATC code - L01EJ
SpainJanus-associated kinase (jak) inhibitors
Drugs with code L01EJ
-
Form: capsules, hard
Active substance Dosage fedratinib dihydrochloride monohydrate 117,3 mg ATC code: L01E, L01EJ, L01EJ02
Manufacturer: Bristol-Myers Squibb Pharma Eeig
-
Form: tablets
Active substance Dosage ruxolitinib 10 mg ATC code: L01E, L01EJ, L01EJ01
Manufacturer: Novartis Europharm Limited
-
Form: tablets
Active substance Dosage ruxolitinib 15 mg ATC code: L01E, L01EJ, L01EJ01
Manufacturer: Novartis Europharm Limited
-
Form: tablets
Active substance Dosage ruxolitinib 20 mg ATC code: L01E, L01EJ, L01EJ01
Manufacturer: Novartis Europharm Limited
-
Form: tablets
Active substance Dosage ruxolitinib 5 mg ATC code: L01E, L01EJ, L01EJ01
Manufacturer: Novartis Europharm Limited
-
Form: solution, oral
Active substance Dosage ruxolitinib phosphate 6,60 mg/ml ATC code: L01E, L01EJ, L01EJ01
Manufacturer: Novartis Europharm Limited
-
Form: tablets, film-coated
Active substance Dosage momelotinib dihydrochloride monohydrate 121,94 mg ATC code: L01E, L01EJ, L01EJ04
Manufacturer: Glaxosmithkline Trading Services Limited
-
Form: tablets, film-coated
Active substance Dosage momelotinib dihydrochloride monohydrate 182,91 mg ATC code: L01E, L01EJ, L01EJ04
Manufacturer: Glaxosmithkline Trading Services Limited
-
Form: tablets, film-coated
Active substance Dosage momelotinib dihydrochloride monohydrate 243,88 mg ATC code: L01E, L01EJ, L01EJ04
Manufacturer: Glaxosmithkline Trading Services Limited